Journal Information
Vol. 42. Issue 8.
Pages 388-393 (August 2006)
Share
Share
Download PDF
More article options
Vol. 42. Issue 8.
Pages 388-393 (August 2006)
Original Articles
Full text access
Bacterial Etiology of Chronic Bronchitis Exacerbations Treated by Primary Care Physicians
Visits
5483
Carles Llora,
Corresponding author
cllor.larte.ics@gencat.net

Correspondence: Dr. C. Llor. Foixarda. 95. 43008 Tarragona. Espana
, Josep Maria Cotsb, Amadeo Herrerasc
a Centro de Salud Jaume I, Tarragona, Spain
b Centro de Salud Marina, Barcelona, Spain. Coordinador del Grupo de Trabajo de Enfermedades Infecciosas de la Sociedad Española de Medicina de Familia
c Médico, Sanofi-Aventis, Barcelona, Spain
This item has received
Article information
Objective

Few studies have been carried out to determine the prevalence of microorganisms causing exacerbations of chronic bronchitis in the community setting. The aim of the present study was to determine the bacterial etiology of chronic bronchitis exacerbations in patients not requiring hospitalization.

Patients and methods

This observational, cross-sectional, multicenter study was carried out at the primary care level during 2 weeks (in November 2001 and January 2002). All laboratory work was carried out at a single center. We studied 1947 patients with mild-moderate exacerbations treated by 650 primary care physicians. All the sputum samples received for centralized processing were subject to Gram staining, microscopic examination, and bacterial culture.

Results

Out of 1537 cultures of sputum samples collected, 498 had good cell quality for microscopic examination (32.4%). Of the 498 good quality samples analyzed, 246 (49.4%) were positive and 468 isolates were obtained. The most commonly isolated germ was Streptococcus pneumonias (163 cases, 34.8%), followed by Moraxella catarrhalis (112, 23.9%), and Haemophilus influenzae (59, 12.6%). In 1.2% of the S pneumoniae isolates resistance was found to amoxicillin; resistance to macrolides was found in 34.3%. The antibiotics most commonly prescribed, however, were macrolides (38.3% of the prescriptions).

Conclusions

S pneumoniae was the microorganism most frequently isolated in cases of chronic bronchitis exacerbation treatable in this outpatient setting.

Key words:
Bronchitis
chronic
Acute exacerbation
Etiology
Objetivo

Pocos estudios se han efectnado en el ámbito comunitario para conocer la prevalencia de microorganismos causantes de agudizaciones de la bronquitis crónica. El objetivo del presente estudio ha sido conocer la etiología bacteriana de la agudización de la bronquitis crónica en pacientes que no han requerido hospitalización.

Pacientes y métodos

Se trata de un estudio observational, transversal y multicéntrico, efectuado en atención primaria de salud durante 2 semanas (noviembre de 2001 y enero de 2002) con un laboratorio central. Participaron 1.947 pacientes afectados de agudización leve-moderada incluidos por un total de 650 médicos de atención primaria. Todas las muestras recibidas se procesaron en un laboratorio central con tinción de Gram, examen microscópico de las muestras y cultivo bacteriano.

Resultados

Entre los 1.537 cultivos de esputo recogidos, 498 presentaron buena calidad celular microscópica (32,4%). De las 498 muestras de esputo de calidad öptima analizadas, fueron positivas 246 (49,4%) y se obtuvieron 468 aislamientos. El germen más comúnmente aislado fue Streptococcus pneumoniae, con 163 casos (34,8%), seguido de Moraxella catarrhalis, con 112 (23,9%), y Haemophilus influenzae, con 59 (12,6%). El 1,2% de los neumococos fueron resistentes a amoxicilina y un 34,3% a los macrólidos. Los antibióticos mayormente prescritos fueron, sin embargo, los macrólidos, en el 38,3% de las ocasiones.

Conclusiones

S. pneumoniae constituye el microorganismo bacteriano que con más frecuencia se aísla de los pacientes que sufren agudizaciones de la bronquitis crönica que pueden ser tratados ambulatoriamente.

Palabras clave:
Bronquitis crónica
Agudización
Etiología
Full text is only aviable in PDF
References
[1]
CJ Murray, AD López.
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease study.
Lancet, 349 (1997), pp. 1498-1504
[2]
DM Mannino.
COPD. Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity.
Chest, 121 (2002), pp. 121S-126S
[3]
JV Hirschmann.
Do bacteria cause exacerbations of COPD?.
Chest, 118 (2000), pp. 193-203
[4]
AJ White, S Gompertz, RA Stockley.
Chronic obstructive pulmonary disease. 6: The aetiology of exacerbations of chronic obstructive pulmonary disease.
Thorax, 58 (2003), pp. 73-80
[5]
G Rohde, A Wiethege, I Borg, M Kauth, TT Baner, A Gillissen, et al.
Respiratory viruses in exacerbations of Chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.
Thorax, 58 (2003), pp. 37-42
[6]
E Monsó, J Ruiz, A Rosell, J Manterola, J Fiz, J Morera, et al.
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.
Am J Respir Crit Care Med, 152 (1995), pp. 1316-1320
[7]
JA Wedzicha.
Exacerbations: etiology and pathophysiologic mechanisms.
Chest, 121 (2002), pp. 136-141
[8]
J Eller, A Ede, T Schaberg, MS Niederman, H Mauch, H Lode.
Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function.
Chest, 113 (1998), pp. 1542-1548
[9]
M Miravitlles, C Espinosa, E Fernández-Laso, JA Martos, JA Maldonado, M Gallego, Study Group of Bacterial Infection in COPD.
Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD.
Chest, 116 (1999), pp. 40-46
[10]
M Miravitlles, C Mayordomo, M Artés, L Sánchez-Agudo, F Nicolau, JL Segú.
Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice.
Respir Med, 93 (1999), pp. 173-179
[11]
E Pérez-Trallero, C García de la Fuente, C García-Rey, F Baquero, L Aguilar, R Dal-Re, Spanish Surveillance Group for Respiratory Pathogens, et al.
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain.
Antimicrob Agents Chemother, 49 (2005), pp. 1965-1972
[12]
JJ Picazo, C Betriu, I Rodríguez-Avial, E Culebras, M Gómez, Grupo VIRA.
Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2004.
Enferm Infecc Microbiol Clin, 22 (2004), pp. 517-525
[13]
American Thoracic Society.
Definition and classification of chronic bronchitis, asthma, and pulmonary emphysema.
Am Res Resp Dis, 85 (1962), pp. 762-768
[14]
PR Murray, JA Washington.
Microscopic and bacteriologic analysis of expectorated sputum.
Mayo Clin Proc, 50 (1975), pp. 339-344
[15]
HS Heineman, JK Chawla, WM Lofton.
Misinformation from sputum cultures without microscopic examination.
J Clin Microbiol, 6 (1977), pp. 518-527
[16]
NR Anthonisen, J Manfreda, CP Warren, CP Warren, ES Herschfield, GK Harding, et al.
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Ann Intern Med, 106 (1987), pp. 196-204
[17]
D Lieberman, O Shmarkov, Y Gelfer, R Varsavsky, DV Lieberman.
Prevalence and clinical significance of fever in acute exacerbations of chronic obstructive pulmonary disease.
Eur J Clin Microbiol Infect Dis, 22 (2003), pp. 75-78
[18]
TF Murphy, S Sethi.
Bacterial infection in chronic obstructive pulmonary disease.
Am Rev Respir Dis, 146 (1992), pp. 1067-1083
[19]
AT Hill, EJ Campbell, SL Hill, DL Bayley, RA Stockley.
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.
Am J Med, 109 (2000), pp. 288-295
[20]
L Davies, I Hadcroft, K Mutton, JE Earis, N Kennedy.
Antimicrobial management of acute exacerbation of chronic airflow limitation.
Q J Med, 94 (2001), pp. 373-378
[21]
N Soler, A Torres, S Ewig, J González, R Celis, M El-Ebiary, et al.
Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.
Am J Respir Crit Care Med, 157 (1998), pp. 1498-1505
[22]
S Sethi, N Evans, BJ Grant, TF Murphy.
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
N Engl J Med, 347 (2002), pp. 465-471
[23]
SW Crooks, DL Bayley, SL Hill, RA Stockley.
Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4.
Eur Respir J, 15 (2000), pp. 274-280
[24]
E Monsó.
Colonizatiön bronquial en la enfermedad pulmonar obstructiva crónica: algo se esconde debajo de la alfombra.
Arch Bronconeumol, 40 (2004), pp. 543-546
[25]
A Rosell, E Monsó, N Soler, F Torres, J Angrill, G Riise, et al.
Microbiologic determinants, of exacerbation in chronic obstructive pulmonary disease.
Arch Intern Med, 165 (2005), pp. 891-897
[26]
IS Patel, TA Seemungal, M Wilks, SJ Lloyd-Owen, GC Donaldson, JA Wedzicha.
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.
Thorax, 57 (2002), pp. 759-764
[27]
M Miravitlles, C Espinosa, E Fernández-Laso, JA Martos, JA Maldonado, M Gallego, et al.
Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD.
Chest, 116 (1999), pp. 40-46
[28]
JL Viejo, MA Fernández, J Laparra.
Estudio epidemiolögico de los agentes patógenos hallados en las agudizaciones de la bronquitis crónica en el norte de España.
Arch Bronconeumol, 33 (1997), pp. 106
[29]
KJ Mobbs, HK Van Saene, D Sunderland, PD Davies.
Oropharyngeal Gram-negative bacillary carriage in chronic obstructive pulmonary disease: relation to severity of disease.
Respir Med, 93 (1999), pp. 540-545
[30]
R Zalacám, V Sobradillo, J Amilibia, J Barrón, V Anchötegui, JI Pijoan, et al.
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.
Eur Respir J, 13 (1999), pp. 343-348
[31]
E Monsó, A Rosell, G Bonet, J Manterola, PJ Cardona, J Ruiz, et al.
Risk factors for lower airway bacterial colonization in chronic bronchitis.
Eur Respir J, 13 (1999), pp. 338-342
[32]
S Sethi.
Infectious etiology of acute exacerbations of chronic bronchitis.
Chest, 117 (2000), pp. 380S-385S
[33]
C Llor, K Naberan, JM Cots, J Molina, M Miravitlles.
Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care centers.
Int J Clin Pract, 58 (2004), pp. 937-944
[34]
J Ruiz.
Tratamiento de la infectión en la exacerbatión de la enfermedad pulmonar obstructiva crónica. Revisión de las guías internacionales y nacionales.
Arch Bronconeumol, 40 (2004), pp. 26-29
[35]
F Álvarez, E Bouza, JA García-Rodríguez, J Mensa, E Monsó, JJ Picazo, et al.
Segundo documento de consenso sobre uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 39 (2003), pp. 274-282
[36]
Grupo de trabajo de la Asociacion Latinoamericana del Tórax (ALAT).
Actualización de las recomendaciones ALAT sobre la exacerbación infecciosa de la EPOC.
Arch Bronconeumol, 40 (2004), pp. 315-325
[37]
Societal Catalana de Medicina de Familia.
Terapèutica de les infeccions de les vies aèries baixes.
Recomanacions sobre l'ús d'antimicrobians en l'Atenció Primària, 5th ed, pp. 35-51

This study received funding from Sanofi-Aventis.

Copyright © 2006. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?